US Patent 8883788 Fused heterocyclic ring compound
Patent 8883788 was granted and assigned to Takeda Pharmaceutical Company on November, 2014 by the United States Patent and Trademark Office.
All edits
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08883788 Fused heterocyclic ring compound US Patent 8883788 Fused heterocyclic ring compound
Infobox
Patent Number
0888378800
Patent Number
888378800
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 6 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
088837880
Date of Patent
November 11, 2014
0Patent Application Number
138140350
Date Filed
August 3, 2011
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
088837880
Date of Patent
November 11, 2014
0Patent Application Number
138140350
Date Filed
August 3, 2011
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 27 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08883788 Fused heterocyclic ring compound
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08883788
Date of patent
November 11, 2014
Patent application number
13814035
Date Filed
August 3, 2011
Patent primary examiner
Find more entities like US Patent 8883788 Fused heterocyclic ring compound
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
